20.2 Transjugular Intrahepatic Portosystemic Shunt (TIPS) & Variceal Interventions

Key Takeaways

  • Diagnostic HVPG uses wedged minus free hepatic venous pressure. Direct procedural PSPG uses measured portal pressure and a documented systemic reference.

  • Preemptive TIPS for selected high-risk bleeding and salvage TIPS for uncontrolled bleeding serve distinct purposes. Refractory ascites, hydrothorax and hepatic outflow obstruction need their own selection.

  • Assess heart function, pulmonary pressure, infection, encephalopathy and venous anatomy. Severe heart failure may decompensate as preload rises.

  • The AASLD acute esophageal bleeding goal is a direct PSPG below 12 mmHg or a reduction of at least 50%. Compare pressures with the same reference.

  • A covered shunt improves patency compared with uncovered devices in randomized evidence. Clinical and imaging follow-up remain necessary.

Last updated: November 2026

20.2 Transjugular Intrahepatic Portosystemic Shunt (TIPS) & Variceal Interventions

Clinical Core: TIPS creates an intrahepatic channel between a portal vein branch and systemic venous outflow. Diverting flow lowers the pressure driving complications such as variceal bleeding or refractory ascites in selected patients. The team balances decompression against the risks of hepatic encephalopathy, hepatic deterioration and increased cardiac preload.

Portal hypertension and two different pressure measurements

Fibrosis, nodules and dynamic vasoconstriction increase hepatic resistance in cirrhosis. Increased splanchnic inflow can further raise the portal pressure gradient. Blood may then reach systemic veins through gastroesophageal and other collaterals. Dilated varices can bleed. Splanchnic vasodilation, fluid retention and raised hydrostatic pressure contribute to ascites and other decompensation.

MeasurementHow it is obtainedInterpretation
Hepatic venous pressure gradient (HVPG)Wedged hepatic venous pressure minus free hepatic venous pressure.The wedge estimates sinusoidal pressure. In viral- and alcohol-related cirrhosis, an HVPG of at least 10 mmHg defines clinically significant portal hypertension. Presinusoidal disease may be underestimated.
Direct portosystemic pressure gradient (PSPG) during TIPSDirect portal vein pressure minus pressure at a documented systemic venous reference. AASLD favors the suprahepatic intra-abdominal IVC.Quantifies the portal-to-systemic gradient before and after shunt creation using a consistent reference. ALTA recommends free hepatic vein or IVC as the reference. A right atrial reading used when IVC measurement is impracticable can give a different gradient.

For example, a wedged pressure of 18 and a free hepatic pressure of 6 give an HVPG of 12 mmHg. A separately measured portal pressure of 30 and IVC pressure of 14 give a direct PSPG of 16 mmHg. Treat each result according to how it was obtained.

Candidacy and procedural purpose

Clinical settingHow TIPS enters the plan
Acute high-risk esophageal or type 1 gastroesophageal variceal bleedingThe 2026 Baveno VIII consensus supports preemptive covered TIPS within 72 hours, ideally before 24 hours, for selected patients. Its criteria include Child-Pugh C 10–13, Child-Pugh B above 7 with active bleeding at initial endoscopy, or HVPG at least 20 mmHg at hemorrhage.
Bleeding uncontrolled by initial treatmentSalvage TIPS may be needed when pharmacologic and endoscopic therapy fail. For subsequent rebleeding despite appropriate secondary prevention, TIPS can also be considered.
Refractory ascites or hepatic hydrothoraxConsider in selected patients after assessment of liver, heart and kidney status and alternative therapy.
Budd–Chiari syndromeA shunt may be appropriate in a stepwise specialist plan when hepatic venous outflow cannot be adequately restored or symptoms persist.

Fundal gastric varices may require a different pathway. Map portal inflow and systemic drainage. Options include TIPS with embolization or retrograde transvenous obliteration when suitable shunt anatomy permits. The two strategies alter portal hemodynamics differently.

For elective TIPS, evaluate portal and hepatic venous anatomy with appropriate cross-sectional imaging and use echocardiography to assess cardiac function and pulmonary pressure. Severe heart failure, severe untreated valvular disease, significant pulmonary hypertension despite optimization, uncontrolled infection and refractory overt encephalopathy are important contraindications in the North American elective setting. Assess physiologic risk with the full clinical picture. ALTA does not prescribe a universal MELD cutoff. Extensive cystic disease can create anatomic obstacles. Acute preemptive selection is a distinct setting, and encephalopathy at admission by itself is not an automatic exclusion under Baveno VIII for patients meeting its criteria.

Portal venous anatomy and portography

The superior mesenteric and splenic veins usually join behind the pancreas to form the main portal vein. The inferior mesenteric vein can enter the splenic vein, confluence or superior mesenteric vein. In the liver, identify the main portal vein, its branches and any alternative pathways. Hepatopetal flow moves toward the liver. Hepatofugal flow moves away from it and can drain through collaterals when portal pressures rise. Normal hepatic veins drain the liver to the IVC, a different circulation from the portal inflow.

Direct portography images contrast delivered into the portal system after access. An indirect study can image portal filling in the venous phase of a selective mesenteric arteriogram. A wedged hepatic venogram can outline portal branches for targeting but does not necessarily show their entire supply and drainage. Record the contrast origin and phase. Look for a filling defect, altered direction, reopened main flow or persistent variceal drainage. Compare before and after intervention. A patent TIPS on portography still needs the relevant pressure and clinical assessment.

Create and assess the shunt

  1. Plan the venous access, portal target and imaging from the patient's anatomy. A common path from the right internal jugular vein passes through the central veins and IVC into a hepatic vein. A right hepatic vein to right portal branch tract is one possible configuration.
  2. Use the selected roadmap and puncture equipment to enter the portal system. A wedged hepatic venogram or intravascular ultrasound can help locate the target in selected cases. Avoid prescribing a fixed puncture angle. Confirm the portal branch by imaging and wire position. Blood color alone is insufficient.
  3. Measure and document baseline direct pressures. Prepare a wire, sheath, tract dilation equipment and dedicated covered stent-graft suited to the plan. In the GORE VIATORR design, the uncovered portal segment provides an open lattice at the portal end, and the covered segment lines the parenchymal tract to the hepatic venous outflow. FDA approved a modified U.S. Controlled Expansion model with a 6–10 mm range in October 2025. Check the specific version and instructions.
  4. Repeat pressure and flow assessment after deployment and any titration. For acute, uncontrolled esophageal variceal bleeding, the 2024 AASLD guidance gives a desired PSPG below 12 mmHg or at least a 50% reduction from baseline. For other indications, including gastric variceal bleeding, the target can differ or be uncertain. The shunt diameter is a means of titration. Assess residual variceal flow and whether adjunctive embolization is appropriate.

Worked case. With the same IVC reference method, a fall from 20 to 11 mmHg is (20−11)/20=45%(20-11)/20=45\%. The resulting 11 mmHg is below 12, so the absolute benchmark is met even though the relative benchmark is not. That result still needs clinical follow-up for bleeding control and adverse effects.

In a randomized comparison of 80 patients, the reported actuarial two-year primary patency was 76% for a covered prosthesis versus 36% for an uncovered one. The difference was 40 percentage points in that study. A covered shunt still needs follow-up.

Surveillance and complications

Check for encephalopathy, liver or heart deterioration, procedural bleeding and recurrent portal-hypertension symptoms. Severe or persistent encephalopathy may lead the team to consider shunt reduction after medical management. New bleeding or hemodynamic instability after puncture warrants prompt evaluation for procedural injury.

After TIPS for variceal hemorrhage, AASLD suggests Doppler at 1 week, 3 months, 6 months and every 6 months thereafter. Use differences in shunt flow, imaging and symptoms together. A single velocity is insufficient to diagnose a shunt stenosis. Venography with manometry can clarify suspected dysfunction, especially when bleeding recurs or imaging raises concern.

Loading diagram...
TIPS Procedural Pathway, Hemodynamic Targets, and Decision Logic
Test Your Knowledge

During TIPS for acute uncontrolled esophageal variceal bleeding, baseline portal and suprahepatic IVC pressures are 30 and 14 mmHg. Post-TIPS direct PSPG is 8 mmHg using the same reference method. What is the baseline and how does the result compare with AASLD guidance?

A

44 mmHg baseline, with an 82% reduction.

B

16 mmHg baseline, and gradients should routinely be lowered to zero.

C

16 mmHg baseline, but an 8 mmHg result represents only an 8% reduction.

D

16 mmHg baseline. An 8 mmHg result is below 12 and is a 50% reduction.

Test Your Knowledge

Which condition most directly argues against elective TIPS because the shunt increases venous return to the heart?

A

Severe symptomatic heart failure despite management.

B

Refractory cirrhotic ascites in an otherwise suitable candidate.

C

A selected high-risk esophageal bleeding presentation meeting criteria for preemptive TIPS.

D

Recurrent esophageal variceal bleeding despite appropriate secondary prevention.

Test Your Knowledge

What is an evidence-supported advantage of a covered TIPS stent-graft over an uncovered prosthesis?

A

It allows blind portal puncture without imaging.

B

It improves primary shunt patency. A design with an uncovered portal segment need not cover adjacent branch origins with fabric.

C

It ensures that post-TIPS encephalopathy cannot occur.

D

It removes the need for follow-up because stenosis is impossible.

Test Your Knowledge

During treatment of portal hypertension, contrast introduced into a portal branch fills a varix and then drains away from the liver into a systemic vein. What does the run show?

A

Normal intrahepatic hepatic venous inflow

B

Proof of portal-to-systemic pressure normalization

C

A patent collateral carrying portal flow away from the liver

D

A delayed arterial phase that cannot inform the direction of venous flow

Sections you finish are checked off in the contents.